Mirador Capital Partners LP Danaher Corp Transaction History

Mirador Capital Partners LP

$546 Million
Q3 2024

A detailed history of Mirador Capital Partners LP transactions in Danaher Corp stock. As of the latest transaction made, Mirador Capital Partners LP holds 22,601 shares of DHR stock, worth $5.27 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

22,601

Previous 22,864 1.15%

Holding current value

$5.27 Million

Previous $5.71 Million 9.98%

% of portfolio

1.15%

Previous 1.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$239.25 - $280.76 $62,922 - $73,839	-263 Reduced 1.15%	22,601 $6.28 Million
Q2 2024 Jul 12, 2024	BUY	$235.51 - $267.98 $141,777 - $161,323	602 Added 2.7%	22,864 $5.71 Million
Q1 2024 Apr 17, 2024	BUY	$224.58 - $256.19 $238,953 - $272,586	1,064 Added 5.02%	22,262 $5.56 Million
Q4 2023 Jan 19, 2024	BUY	$185.1 - $233.13 $183,249 - $230,798	990 Added 4.9%	21,198 $4.9 Million
Q3 2023 Oct 05, 2023	BUY	$233.08 - $265.59 $78,081 - $88,972	335 Added 1.69%	20,208 $5.01 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $35,098 - $39,957	156 Added 0.79%	19,873 $4.77 Million
Q1 2023 Apr 14, 2023	SELL	$239.75 - $277.0 $275,952 - $318,827	-1,151 Reduced 5.52%	19,717 $4.97 Million
Q4 2022 Feb 09, 2023	SELL	$241.42 - $282.29 $78,702 - $92,026	-326 Reduced 1.54%	20,868 $5.54 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $25,941 - $158,277	105 Added 0.5%	21,194 $5.47 Million
Q2 2022 Aug 05, 2022	BUY	$237.11 - $299.66 $19,917 - $25,171	84 Added 0.4%	21,089 $5.35 Million
Q1 2022 May 06, 2022	BUY	$257.27 - $315.76 $129,406 - $158,827	503 Added 2.45%	21,005 $6.16 Million
Q4 2021 Feb 02, 2022	BUY	$292.08 - $329.01 $226,069 - $254,653	774 Added 3.92%	20,502 $6.75 Million
Q3 2021 Nov 09, 2021	BUY	$272.21 - $332.43 $99,628 - $121,669	366 Added 1.89%	19,728 $6.01 Million
Q2 2021 Jul 27, 2021	BUY	$225.08 - $271.69 $229,356 - $276,852	1,019 Added 5.56%	19,362 $5.2 Million
Q1 2021 Apr 29, 2021	BUY	$212.38 - $245.9 $399,274 - $462,292	1,880 Added 11.42%	18,343 $4.13 Million
Q4 2020 Jan 20, 2021	BUY	$212.5 - $245.46 $496,612 - $573,640	2,337 Added 16.54%	16,463 $3.66 Million
Q3 2020 Nov 12, 2020	BUY	$177.16 - $215.33 $69,978 - $85,055	395 Added 2.88%	14,126 $3.04 Million
Q2 2020 Aug 06, 2020	BUY	$128.7 - $176.83 $21,621 - $29,707	168 Added 1.24%	13,731 $2.43 Million
Q1 2020 May 11, 2020	BUY	$121.39 - $169.05 $210,004 - $292,456	1,730 Added 14.62%	13,563 $2.22 Million
Q4 2019 Jan 17, 2020	SELL	$133.47 - $153.48 $26,427 - $30,389	-198 Reduced 1.65%	11,833 $1.82 Million
Q3 2019 Oct 31, 2019	SELL	$135.4 - $146.47 $26,403 - $28,561	-195 Reduced 1.59%	12,031 $1.74 Million
Q2 2019 Aug 06, 2019	SELL	$124.88 - $143.73 $17,483 - $20,122	-140 Reduced 1.13%	12,226 $1.75 Million
Q1 2019 May 14, 2019	SELL	$97.62 - $132.29 $33,581 - $45,507	-344 Reduced 2.71%	12,366 $1.63 Million
Q4 2018 Feb 13, 2019	SELL	$94.85 - $109.54 $24,945 - $28,809	-263 Reduced 2.03%	12,710 $1.31 Million
Q3 2018 Nov 13, 2018	BUY	$98.13 - $108.9 $94,302 - $104,652	961 Added 8.0%	12,973 $1.41 Million
Q2 2018 Aug 08, 2018	SELL	$96.1 - $103.24 $9,610 - $10,324	-100 Reduced 0.83%	12,012 $1.19 Million
Q1 2018 May 02, 2018	BUY	$92.16 - $103.8 $3,225 - $3,633	35 Added 0.29%	12,112 $1.22 Million
Q4 2017 Feb 12, 2018	BUY	$85.26 - $94.62 $1,875 - $2,081	22 Added 0.18%	12,077 $1.12 Million
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $8,166 - $9,110	103 Added 0.86%	12,055 $1.04 Million
Q2 2017 Aug 08, 2017	BUY	N/A	11,952	11,952 $968,000

Others Institutions Holding DHR

# of Institutions

2,507

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $170B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Account

Mirador Capital Partners LP Danaher Corp Transaction History